MANAGEMENT OF DYSPAREUNIA IN POSTMENOPAUSAL WOMEN: RESTORATION OF SEXUAL HEALTH AND QUALITY OF LIFE
Nazarova N.M., Devyatkina A.R., Akopyan A.S., Mezhevitinova E.A., Sycheva E.G., Prilepskaya V.N.
For citation: Nazarova N.M., Devyatkina A.R., Akopyan A.S., Mezhevitinova E.A., Sycheva E.G., Prilepskaya V.N. Management of dyspareunia in postmenopausal women: restoration of sexual health and quality of life. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (12 Suppl.): 9-14 (in Russian)
https://dx.doi.org/10.18565/aig.2025.280
References
1. Cagnacci A., Carbone M.M., Palma F. Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study. Menopause. 2016; 23(10): 1139‑45. https://dx.doi.org/10.1097/GME.0000000000000675
2. Freedman M.A. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Womens Health (Lond.). 2014; 10(4): 445‑54. https://dx.doi.org/10.2217/whe.14.29
3. Tayyeb M., Gupta V. Dyspareunia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
4. Traish A.M., Vignozzi L., Simon J.A., Goldstein I., Kim N.N. Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause. Sex. Med. Rev. 2018; 6(4): 558‑71. https://dx.doi.org/10.1016/j.sxmr.2018.03.005
5. Arora V., Mukhopadhyay S., Morris E. Painful sex (dyspareunia): a difficult symptom in gynecological practice. Obstet. Gynaecol. Reprod. Med. 2020; 30(9): 269‑75. https://dx.doi.org/10.1016/j.ogrm.2020.06.001
6. Li T., Ma Y., Zhang H., Yan P., Huo L., Hu Y. et al. Estrogen replacement regulates vaginal innervations in ovariectomized adult virgin rats: a histological study. Biomed. Res. Int. 2017; 2017: 7456853. https://dx.doi.org/10.1155/2017/7456853
7. Mónica Brauer M., Smith P.G. Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity. Auton. Neurosci. 2015; 187: 1‑17. https://doi.org/10.1016/j.autneu.2014.11.009
8. Ting A.Y., Blacklock A.D., Smith P.G. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol. Reprod. 2004; 71(4): 1397‑404. https://doi.org/10.1095/biolreprod.104.030023
9. Beck L.A., Cork M.J., Amagai M., De Benedetto A., Kabashima K., Hamilton J.D. et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov. 2022; 2(5): 100131. https://dx.doi.org/10.1016/j.xjidi.2022.100131
10. Takahashi S., Ishida A., Kubo A., Kawasaki H., Ochiai S., Nakayama M. et al. Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier‑impaired skin during chronic itch development. Sci. Rep. 2019; 9(1): 8625. https://dx.doi.org/10.1038/s41598‑019‑44866‑0
11. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Менопауза и климактерическое состояние у женщины. М.; 2021. 86 с. [Ministry of Health of the Russian Federation. Clinical guidelines. Menopause and menopausal symptoms in woman. Moscow; 2021. 86 p. (in Russian)].
12. Mac Bride M.B., Rhodes D.J., Shuster L.T. Vulvovaginal atrophy. Mayo Clin. Proc. 2010; 85(1): 87‑94. https://dx.doi.org/10.4065/mcp.2009.0413
13. Nappi R.E., Martini E., Cucinella L., Martella S., Tiranini L., Inzoli A. et al. Addressing vulvovaginal atrophy (VVA) / genitourinary syndrome of menopause (GSM) for healthy aging in women. Front. Endocrinol. (Lausanne). 2019; 10: 561. https://dx.doi.org/10.3389/fendo.2019.00561
14. Weber M.A., Limpens J., Roovers J.P. Assessment of vaginal atrophy: a review. Int. Urogynecol. J. 2015; 26(1): 15‑28. https://dx.doi.org/10.1007/s00192‑014‑2464‑0
15. Barton D.L., Sloan J.A., Shuster L.T., Gill P., Griffin P., Flynn K. et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support. Care Cancer. 2018; 26(2): 643‑50. https://dx.doi.org/10.1007/s00520‑017‑3878‑2
16. Инструкция по применению лекарственного препарата для медицинского применения Мойстана® (Moistana) [РЗН 2023/21844 от 29.12.2023]. Доступно по: https://www.vidal.ru/drugs/moistana [Instructions for use of a medicinal product for medical use Moistana [RZN 2023/21844 dated 29.12.2023]. Available at: https://www.vidal.ru/drugs/moistana (in Russian)].
17. Инструкция по применению лекарственного препарата для медицинского применения Интрароса® (Intrarosa®) [ЛП‑N=(004049)‑(РГ‑RU) от 19.12.2023]. Доступно по: https://www.vidal.ru/drugs/intrarosa [Instructions for use of a medicinal product for medical use Intrarosa® [LP‑N=(004049)‑(RG‑RU) dated 19.12.2023]. Available at: https://www.vidal.ru/drugs/intrarosa (in Russian)].
18. Bouchard C., Labrie F., Derogatis L., Girard G., Ayotte N., Gallagher J. et al. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC‑230 open‑label study. Horm. Mol. Biol. Clin. Investig. 2016; 25(3): 181‑90. https://dx.doi.org/10.1515/hmbci‑2015‑0044
About the Authors
Niso M. Nazarova, Dr. Med. Sci., Leading Researcher, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, n_nazarova@oparina4.ru, https://orcid.org/0000-0001-9499-7654Anastasia R. Devyatkina, obstetrician-gynecologist, PhD student, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, grinasta26@mail.ru, https://orcid.org/0009-0006-1742-7555
Aida S. Akopyan, obstetrician-gynecologist, Applicant, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, aida.doctor@mail.ru, https://orcid.org/0009-0006-7277-5202
Elena G. Sycheva, PhD, doctor at the Scientific Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, el.bona@mail.ru, https://orcid.org/0000-0002-2527-7853
Elena A. Mezhevitinova, Dr. Med. Sci., Leading Researcher at the Scientific Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, mejevitinova@mail.ru, https://orcid.org/0000-0003-2977-9065
Vera N. Prilepskaya, Dr. Med. Sci., Professor, Head of the Scientific Polyclinic Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, v_prilepskaya@oparina4.ru, https://orcid.org/0000-0003-3993-7629
